Chemoinformaics analysis of (E)-OCTADEC-9-ENOIC ACID
| Molecular Weight | 282.468 | nRot | 15 |
| Heavy Atom Molecular Weight | 248.196 | nRig | 2 |
| Exact Molecular Weight | 282.256 | nRing | 0 |
| Solubility: LogS | -0.342 | nHRing | 0 |
| Solubility: LogP | -1.979 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 54.335 |
| nHD | 1 | BPOL | 34.977 |
| QED | 0.475 |
| Synth | 3.501 |
| Natural Product Likeliness | -0.044 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.075 |
| HIA | 0.015 |
| CACO-2 | -6.115 |
| MDCK | 0.00344282 |
| BBB | 0.4 |
| PPB | 0.0857975 |
| VDSS | 0.49 |
| FU | 0.929886 |
| CYP1A2-inh | 0.007 |
| CYP1A2-sub | 0.491 |
| CYP2c19-inh | 0.019 |
| CYP2c19-sub | 0.067 |
| CYP2c9-inh | 0.011 |
| CYP2c9-sub | 0.45 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.126 |
| CYP3a4-inh | 0.01 |
| CYP3a4-sub | 0.071 |
| CL | 2.141 |
| T12 | 0.648 |
| hERG | 0.009 |
| Ames | 0.028 |
| ROA | 0.003 |
| SkinSen | 0.171 |
| Carcinogencity | 0.023 |
| EI | 0.128 |
| Respiratory | 0.031 |
| NR-Aromatase | 0.002 |
| Antiviral | Yes |
| Prediction | 0.576912 |